Clinical trial
Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related…
NCT00304447 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00304447 |
|---|---|
| Title | Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia |
| Official title | A Phase IV Study of Corticosteroids As Prophylaxis for Infusion-Related Adverse Events to Mylotarg® in Patients With Acute Myelogenous Leukemia (AML) |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Leukemia, Myelocytic, Acute, Infusions, Intravenous |
| Intervention type | Drug |
| Interventions | Mylotarg |
| Enrollment | 30 |
| Start date | Apr 1, 2002 |
| Completion | Jan 1, 2004 |
| First posted | Mar 17, 2006 |
| Last update posted | Jul 29, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: